MagForce AG, a medical device company, operates in the field of nanotechnology-based cancer treatment in Germany. It offers NanoTherm therapy for the treatment of solid tumors; NanoTherm, a ferrofluid liquid that reacts to the presence of a magnetic field; NanoPlan, a therapy planning software; and NanoActivator, a magnetic field applicator used for tumors in all areas of the body. The company was founded in 1997 and is headquartered in Berlin, Germany.
magforce ag (MF6:Xetra)
Phone: 49 30 308 380 0
Fax: 49 30 308 380 99www.magforce.de
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for MF6.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact MAGFORCE AG, please visit www.magforce.de. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.